Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov;9(11):4607-4650.
doi: 10.21037/jtd.2017.10.112.

Chinese Guideline on allergen immunotherapy for allergic rhinitis

Affiliations
Review

Chinese Guideline on allergen immunotherapy for allergic rhinitis

Yixiao Bao et al. J Thorac Dis. 2017 Nov.

Abstract

The present document is based on a consensus reached by a panel of experts from Chinese Society of Allergy (CSA) and Chinese Allergic Rhinitis Collaborative Research Group (C2AR2G). Allergen immunotherapy (AIT), has increasingly been used as a treatment for allergic rhinitis (AR) globally, as it has been shown to provide a long-term effect in improving nasal and ocular symptoms, reducing medication need, and improving quality of life. AIT is currently the only curative intervention that can potentially modify the immune system in individuals suffering from AR and prevent the development of new sensitization and the progression of disease from AR to asthma. Although the use of AIT is becoming more acceptable in China, to date no AR immunotherapy guideline from China is available for use by the international community. This document has thus been produced and covers the main aspects of AIT undertaken in China; including selection of patients for AIT, the allergen extracts available on the Chinese market, schedules and doses of allergen employed in different routes of AIT, assessment of effect and safety, patients' administration and follow-up, and management of adverse reactions. The Chinese guideline for AR immunotherapy will thus serve as a reference point by doctors, healthcare professionals and organizations involved in the AIT of AR in China. Moreover, this guideline will serve as a source of information for the international community on AIT treatment strategies employed in China.

Keywords: Allergen immunotherapy (AIT); China; allergic rhinitis (AR); guideline.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Algorithm and annotations for immunotherapy. AR, allergic rhinitis; AIT, allergen immunotherapy; FEV1, forced expiratory volume in one second.
Figure 2
Figure 2
Drugs in the crash cart for emergency use.
Figure 3
Figure 3
Essential emergency equipment in immunotherapy centre. (A) The emergency room bed; (B) the mucus suction pump; (C) the oxygen tank; (D) bag valve mask, blood pressure meter and stethoscope; (E) the endotracheal tube.
Figure 4
Figure 4
Flow chart for administration of specific immunotherapy. The scope surrounded by red dot lines is the scope for the institute. AR, allergic rhinitis; SPT, skin prick test; sIgE, specific immunoglobulin E.

References

    1. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63 Suppl 86:8-160. 10.1111/j.1398-9995.2007.01620.x - DOI - PubMed
    1. Grossman J. One airway, one disease. Chest 1997;111:11S-6S. 10.1378/chest.111.2_Supplement.11S - DOI - PubMed
    1. Spergel JM. Atopic march: link to upper airways. Curr Opin Allergy Clin Immunol 2005;5:17-21. 10.1097/00130832-200502000-00005 - DOI - PubMed
    1. Bell IR, Jasnoski ML, Kagan J, et al. Depression and allergies: survey of a nonclinical population. Psychother Psychosom 1991;55:24-31. 10.1159/000288404 - DOI - PubMed
    1. Cuffel B, Wamboldt M, Borish L, et al. Economic consequences of comorbid depression, anxiety, and allergic rhinitis. Psychosomatics 1999;40:491-6. 10.1016/S0033-3182(99)71187-4 - DOI - PubMed